Exponent (EXPO) Competitors

92.4% of Exponent shares are owned by institutional investors. Comparatively, 91.8% of Booz Allen Hamilton shares are owned by institutional investors. 1.7% of Exponent shares are owned by insiders. Comparatively, 1.1% of Booz Allen Hamilton shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Exponent presently has a consensus price target of $81.00, suggesting a potential upside of 18.59%. Booz Allen Hamilton has a consensus price target of $83.69, suggesting a potential upside of 8.52%. Given Exponent's stronger consensus rating and higher possible upside, equities research analysts plainly believe Exponent is more favorable than Booz Allen Hamilton.

Booz Allen Hamilton has higher revenue and earnings than Exponent. Booz Allen Hamilton is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Exponent pays an annual dividend of $1.24 per share and has a dividend yield of 1.8%. Booz Allen Hamilton pays an annual dividend of $2.36 per share and has a dividend yield of 3.1%. Exponent pays out 55.6% of its earnings in the form of a dividend. Booz Allen Hamilton pays out 37.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Exponent has raised its dividend for 12 consecutive years and Booz Allen Hamilton has raised its dividend for 14 consecutive years. Booz Allen Hamilton is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Exponent has a net margin of 17.67% compared to Booz Allen Hamilton's net margin of 7.01%. Booz Allen Hamilton's return on equity of 76.71% beat Exponent's return on equity.

Exponent has a beta of 0.68, indicating that its stock price is 32% less volatile than the broader market. Comparatively, Booz Allen Hamilton has a beta of 0.36, indicating that its stock price is 64% less volatile than the broader market.

In the previous week, Booz Allen Hamilton had 5 more articles in the media than Exponent. MarketBeat recorded 7 mentions for Booz Allen Hamilton and 2 mentions for Exponent. Exponent's average media sentiment score of 0.55 beat Booz Allen Hamilton's score of 0.48 indicating that Exponent is being referred to more favorably in the media.

In the previous week, Andersen Group and Andersen Group both had 2 articles in the media. Exponent's average media sentiment score of 0.55 beat Andersen Group's score of 0.00 indicating that Exponent is being referred to more favorably in the news media.

Andersen Group presently has a consensus target price of $54.00, indicating a potential downside of 1.87%. Exponent has a consensus target price of $81.00, indicating a potential upside of 18.59%. Given Exponent's higher possible upside, analysts clearly believe Exponent is more favorable than Andersen Group.

Exponent has lower revenue, but higher earnings than Andersen Group. Andersen Group is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

92.4% of Exponent shares are held by institutional investors. 13.0% of Andersen Group shares are held by company insiders. Comparatively, 1.7% of Exponent shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Exponent has a net margin of 17.67% compared to Andersen Group's net margin of 0.00%. Exponent's return on equity of 31.48% beat Andersen Group's return on equity.

92.4% of Exponent shares are owned by institutional investors. Comparatively, 41.7% of Planet Labs PBC shares are owned by institutional investors. 1.7% of Exponent shares are owned by insiders. Comparatively, 16.4% of Planet Labs PBC shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Exponent has higher revenue and earnings than Planet Labs PBC. Planet Labs PBC is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

Exponent presently has a consensus target price of $81.00, suggesting a potential upside of 18.59%. Planet Labs PBC has a consensus target price of $32.78, suggesting a potential upside of 99.79%. Given Planet Labs PBC's higher possible upside, analysts plainly believe Planet Labs PBC is more favorable than Exponent.

Exponent has a net margin of 17.67% compared to Planet Labs PBC's net margin of -95.13%. Exponent's return on equity of 31.48% beat Planet Labs PBC's return on equity.

In the previous week, Planet Labs PBC had 18 more articles in the media than Exponent. MarketBeat recorded 20 mentions for Planet Labs PBC and 2 mentions for Exponent. Exponent's average media sentiment score of 0.55 beat Planet Labs PBC's score of 0.39 indicating that Exponent is being referred to more favorably in the media.

Exponent has a beta of 0.68, meaning that its share price is 32% less volatile than the broader market. Comparatively, Planet Labs PBC has a beta of 2.1, meaning that its share price is 110% more volatile than the broader market.

Science Applications International has higher revenue and earnings than Exponent. Science Applications International is trading at a lower price-to-earnings ratio than Exponent, indicating that it is currently the more affordable of the two stocks.

92.4% of Exponent shares are held by institutional investors. Comparatively, 76.0% of Science Applications International shares are held by institutional investors. 1.7% of Exponent shares are held by insiders. Comparatively, 0.7% of Science Applications International shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Exponent has a net margin of 17.67% compared to Science Applications International's net margin of 5.13%. Science Applications International's return on equity of 34.68% beat Exponent's return on equity.

Exponent currently has a consensus target price of $81.00, indicating a potential upside of 18.59%. Science Applications International has a consensus target price of $125.22, indicating a potential downside of 5.98%. Given Exponent's stronger consensus rating and higher probable upside, research analysts clearly believe Exponent is more favorable than Science Applications International.

Exponent pays an annual dividend of $1.24 per share and has a dividend yield of 1.8%. Science Applications International pays an annual dividend of $1.48 per share and has a dividend yield of 1.1%. Exponent pays out 55.6% of its earnings in the form of a dividend. Science Applications International pays out 17.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Exponent has raised its dividend for 12 consecutive years. Exponent is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Exponent has a beta of 0.68, meaning that its stock price is 32% less volatile than the broader market. Comparatively, Science Applications International has a beta of 0.3, meaning that its stock price is 70% less volatile than the broader market.

In the previous week, Science Applications International had 3 more articles in the media than Exponent. MarketBeat recorded 5 mentions for Science Applications International and 2 mentions for Exponent. Science Applications International's average media sentiment score of 0.67 beat Exponent's score of 0.55 indicating that Science Applications International is being referred to more favorably in the news media.